Literature DB >> 100108

The distribution of hydrolytic enzyme activities in human fibroblast cultures and their intercellular transfer.

D J Halley, H A de Wit-Verbeek, A J Reuser, H Galjaard.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 100108     DOI: 10.1016/0006-291x(78)90310-8

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


× No keyword cloud information.
  7 in total

Review 1.  Biochemistry and genetics of gangliosidoses.

Authors:  K Sandhoff; H Christomanou
Journal:  Hum Genet       Date:  1979       Impact factor: 4.132

2.  Excretion-reuptake route of beta-hexosaminidase in normal and I-cell disease cultured fibroblasts.

Authors:  G D Vladutiu; M C Rattazzi
Journal:  J Clin Invest       Date:  1979-04       Impact factor: 14.808

3.  Lysosomal enzyme activities and RNA turnover rates in growing and nongrowing WI-38 and HeLa cells.

Authors:  B K Saha; M Sameshima; F Sameshima; D Schlessinger
Journal:  In Vitro       Date:  1981-09

4.  The stability and aggregation properties of human liver acid beta-D-galactosidase.

Authors:  C M Heyworth; E F Neumann; C H Wynn
Journal:  Biochem J       Date:  1981-03-01       Impact factor: 3.857

5.  The expression of hex A and hex B isozymes of hexosaminidase in parental and experimental human fibroblast cells and their components.

Authors:  M T Bladon
Journal:  Biochem Genet       Date:  1981-10       Impact factor: 1.890

6.  Characterization of inducible models of Tay-Sachs and related disease.

Authors:  Timothy J Sargeant; Deborah J Drage; Susan Wang; Apostolos A Apostolakis; Timothy M Cox; M Begoña Cachón-González
Journal:  PLoS Genet       Date:  2012-09-20       Impact factor: 5.917

7.  Insights into post-translational processing of beta-galactosidase in an animal model resembling late infantile human G-gangliosidosis.

Authors:  R Kreutzer; M Kreutzer; M J Pröpsting; A C Sewell; T Leeb; H Y Naim; W Baumgärtner
Journal:  J Cell Mol Med       Date:  2007-12-14       Impact factor: 5.310

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.